Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

Clinical trial NCT00258687 · COMPLETED

Trial details

NCT number: NCT00258687
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma, Clear Cell Sarcoma, Alveolar Soft Part Renal Cell Carcinoma Melanoma

Start date: 2005-01-01
Primary completion: 2006-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.